-
1
المؤلفون: Daniela Ungureanu, Hannu Sariola, Astrid Murumägi, Minna Koskenvuo, Olli Kallioniemi, Jukka Kanerva, Mariliina Arjama, Ralf Bützow, Jouko Lohi
المساهمون: Institute for Molecular Medicine Finland, Precision Systems Medicine, Helsinki Institute of Life Science HiLIFE, University of Helsinki, ATG - Applied Tumor Genomics, Research Programs Unit, Faculty of Medicine, HUSLAB, Department of Pathology, Helsinki University Hospital Area, Helsinki One Health (HOH), Hannu Sariola / Principal Investigator, Department of Biochemistry and Developmental Biology, HUS Children and Adolescents, Children's Hospital, Clinicum, Tampere University, BioMediTech
المصدر: Translational Oncology
Translational Oncology, Vol 14, Iss 4, Pp 101027-(2021)مصطلحات موضوعية: 0301 basic medicine, Cancer Research, Pediatric cancer, medicine.drug_class, HIPEC, heated intraperitoneal chemotherapy, 3122 Cancers, Patient-derived cancer cells, lcsh:RC254-282, DSS, drug sensitivity score, PDC, patient-derived cancer cells, 03 medical and health sciences, 0302 clinical medicine, hemic and lymphatic diseases, STRN-ALK, medicine, Anaplastic lymphoma kinase, Malignant peritoneal mesothelioma, Original Research, Cisplatin, Crizotinib, CRS, cytoreductive surgery, business.industry, Cancer, MPeM, malignant peritoneal mesothelioma, hemic and immune systems, Drug testing, medicine.disease, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, NACT, neoadjuvant chemotherapy, Gemcitabine, 3. Good health, CT, computed tomography, ALK inhibitor, PET-CT, positron emission tomography-computed tomography, 030104 developmental biology, Oncology, Kinase inhibitors, 030220 oncology & carcinogenesis, Cancer cell, Cancer research, DSRT, drug sensitivity and resistance testing, 3111 Biomedicine, business, MRI, magnetic resonance imaging, CRP, C-reactive protein levels, medicine.drug
وصف الملف: fulltext